Literature DB >> 13316683

Meprobamate (equanil) for relief of anxiety and nervous tension from various causes.

S E TURVEY.   

Abstract

Entities:  

Keywords:  ANTICONVULSANTS/therapeutic use; ANXIETY/therapy; MUSCLE RELAXANTS/therapeutic use

Mesh：

Substances：

Year:  1956        PMID： 13316683      PMCID： PMC1824667     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Clinical study of a new tranquilizing drug; use of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate).

Authors:  L S SELLING
Journal:  J Am Med Assoc       Date:  1955-04-30

2.  New tranquilizing drugs.

Authors:  F LEMERE
Journal:  Northwest Med       Date:  1955-10

3.  The central depressant properties of o-toloxypropyl carbamates.

Authors:  F M BERGER
Journal:  J Pharmacol Exp Ther       Date:  1952-04       Impact factor: 4.030

4.  Study of effect of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate) on psychiatric states.

Authors:  J C BORRUS
Journal:  J Am Med Assoc       Date:  1955-04-30

5.  Effect of 2-methyl, 2-n-propyl-1,3-propanediol dicarbamate (Miltown) on central nervous system.

Authors:  C D HENDLEY; T E LYNES; F M BERGER
Journal:  Proc Soc Exp Biol Med       Date:  1954-12
  5 in total
  2 in total

1.  Meprobamate in the treatment of stuttering.

Authors:  R D MAXWELL; J W PATERSON
Journal:  Br Med J       Date:  1958-04-12

2.  An investigation of ataraxics in labour: meprobamate (equanil).

Authors:  J J CARROLL; R S MOIR
Journal:  Can Anaesth Soc J       Date:  1959-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.